Recombinant Escherichia coli cdtC Protein ，His & Myc

The study of recombinant cdtC protein has emerged as a significant focus in microbial pathogenicity research, particularly concerning the bacterium *Helicobacter pylori*. This bacterium is notorious for its role in chronic gastritis, peptic ulcers, and even gastric cancer. The cdtC gene encodes a component of the cytolethal distending toxin (CDT), a virulence factor that affects host cells by inducing cell cycle arrest and apoptosis. Understanding the structure and function of the cdtC protein is crucial, as it may reveal potential therapeutic targets and contribute to the development of vaccines. Recent advances in genetic engineering have facilitated the production of recombinant cdtC proteins, enabling detailed studies of their immunogenic properties and interactions with host immune responses. Additionally, investigations into the functional mechanisms of CDT have underscored its role in immune evasion, making it even more relevant for therapeutic strategies against *H. pylori*-associated diseases. Furthermore, the recombinant form of cdtC can be exploited in experimental models to assess its effects on host cells, paving the way for a deeper understanding of pathogenic mechanisms and the design of novel intervention strategies. As research continues to unravel the complexities of the cdtC protein and its implications in *H. pylori* pathogenesis, it holds promise for enhancing our comprehension of bacterial virulence factors and their impact on human health.